Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Haemonetics Corporation HAE

Full chart Compare
Set alert

Price alert · HAE

All alert types
120.28 USD +0.14 (+0.12%)

At closeNov 3, 2026, 6:47 PM EST

120.28 0.00 0.00%

After hours · Nov 3, 6:47 PM ET

119.00 Day range 121.44
49.96 52-week range 123.77
YTD
+50.07%
1 year
+139.27%

Financial health

Altman Z-Score

3.39 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 3
  • Return on Equity 4
  • Return on Assets 4
  • Debt / Equity 1
  • P/E 2
  • P/B 2

Valuation

P/E 26.4×
FY 2017: -79.5×FY 2018: 85.1×FY 2019: 83.9×FY 2020: 66.0×FY 2021: 70.7×FY 2022: 74.4×FY 2023: 36.5×FY 2024: 36.5×FY 2025: 19.1×FY 2026: 26.4×
FY 2017 5y median 36.5× FY 2026
P/S 1.9×
FY 2017: 2.4×FY 2018: 4.3×FY 2019: 4.8×FY 2020: 5.1×FY 2021: 6.5×FY 2022: 3.2×FY 2023: 3.6×FY 2024: 3.3×FY 2025: 2.3×FY 2026: 1.9×
FY 2017 5y median 3.2× FY 2026
P/B 3.2×
FY 2017: 2.8×FY 2018: 5.1×FY 2019: 6.9×FY 2020: 8.6×FY 2021: 7.7×FY 2022: 4.3×FY 2023: 5.1×FY 2024: 4.5×FY 2025: 3.9×FY 2026: 3.2×
FY 2017 5y median 4.3× FY 2026
P/FCF 9.8×
FY 2017: 25.0×FY 2018: 26.5×FY 2019: 115×FY 2020: 46.2×FY 2021: 78.4×FY 2022: 42.6×FY 2023: 25.8×FY 2024: 29.9×FY 2025: 22.3×FY 2026: 9.8×
FY 2017 5y median 25.8× FY 2026
EV/EBITDA 13.1×
FY 2017: 17.6×FY 2018: 25.7×FY 2019: 24.9×FY 2020: 19.4×FY 2021: 33.7×FY 2022: 18.5×FY 2023: 18.0×FY 2024: 16.2×FY 2025: 11.3×FY 2026: 13.1×
FY 2017 5y median 16.2× FY 2026
EV/Sales 2.6×
FY 2017: 2.6×FY 2018: 4.4×FY 2019: 5.0×FY 2020: 5.4×FY 2021: 7.1×FY 2022: 3.8×FY 2023: 4.0×FY 2024: 3.8×FY 2025: 3.0×FY 2026: 2.6×
FY 2017 5y median 3.8× FY 2026
FCF Yield 10.2%
FY 2017: 4.0%FY 2018: 3.8%FY 2019: 0.9%FY 2020: 2.2%FY 2021: 1.3%FY 2022: 2.3%FY 2023: 3.9%FY 2024: 3.3%FY 2025: 4.5%FY 2026: 10.2%
FY 2017 5y median 3.9% FY 2026

Profitability

Gross Margin 55.7%
FY 2017: 42.7%FY 2018: 45.6%FY 2019: 43.2%FY 2020: 49.4%FY 2021: 49.2%FY 2022: 53.4%FY 2023: 53.3%FY 2024: 54.4%FY 2025: 57.2%FY 2026: 55.7%
FY 2017 5y median 54.4% FY 2026
Operating Margin 18.1%
FY 2017: -2.2%FY 2018: 6.2%FY 2019: 8.6%FY 2020: 10.5%FY 2021: 10.3%FY 2022: 8.1%FY 2023: 13.4%FY 2024: 12.6%FY 2025: 16.3%FY 2026: 18.1%
FY 2017 5y median 13.4% FY 2026
Net Margin 7.3%
FY 2017: -3.0%FY 2018: 5.0%FY 2019: 5.7%FY 2020: 7.7%FY 2021: 9.1%FY 2022: 4.4%FY 2023: 9.9%FY 2024: 9.0%FY 2025: 12.3%FY 2026: 7.3%
FY 2017 5y median 9.0% FY 2026
ROE 12.2%
FY 2017: -3.6%FY 2018: 6.1%FY 2019: 8.2%FY 2020: 13.0%FY 2021: 10.9%FY 2022: 5.8%FY 2023: 14.1%FY 2024: 12.2%FY 2025: 20.4%FY 2026: 12.2%
FY 2017 5y median 12.2% FY 2026
ROIC 8.7%
FY 2017: -1.7%FY 2018: 4.1%FY 2019: 5.9%FY 2020: 8.4%FY 2021: 5.6%FY 2022: 3.4%FY 2023: 7.5%FY 2024: 6.7%FY 2025: 8.1%FY 2026: 8.7%
FY 2017 5y median 7.5% FY 2026
ROA 4.1%
FY 2017: -2.1%FY 2018: 3.7%FY 2019: 4.3%FY 2020: 6.0%FY 2021: 4.4%FY 2022: 2.3%FY 2023: 6.0%FY 2024: 5.4%FY 2025: 6.8%FY 2026: 4.1%
FY 2017 5y median 5.4% FY 2026

Growth (YoY)

Revenue -2.0%
FY 2017: -2.5%FY 2018: 2.0%FY 2019: 7.0%FY 2020: 2.2%FY 2021: -11.9%FY 2022: 14.1%FY 2023: 17.7%FY 2024: 12.0%FY 2025: 4.0%FY 2026: -2.0%
FY 2017 FY 2026
Operating Income 8.8%
FY 2017: 55.9%FY 2018: 389.8%FY 2019: 48.8%FY 2020: 23.7%FY 2021: -13.2%FY 2022: -10.0%FY 2023: 93.2%FY 2024: 5.7%FY 2025: 34.5%FY 2026: 8.8%
FY 2017 FY 2026
EPS (diluted) -38.1%
FY 2017: 53.2%FY 2018: 266.7%FY 2019: 22.4%FY 2020: 42.3%FY 2021: 4.7%FY 2022: -45.8%FY 2023: 166.7%FY 2024: 2.2%FY 2025: 44.5%FY 2026: -38.1%
FY 2017 FY 2026
Free Cash Flow 82.8%
FY 2017: 329.6%FY 2018: 74.1%FY 2019: -72.3%FY 2020: 171.5%FY 2021: -34.4%FY 2022: 5.6%FY 2023: 115.0%FY 2024: -11.8%FY 2025: -0.8%FY 2026: 82.8%
FY 2017 FY 2026

Financial Health

Current Ratio 3.0×
FY 2017: 2.4×FY 2018: 1.4×FY 2019: 2.4×FY 2020: 2.2×FY 2021: 2.7×FY 2022: 1.7×FY 2023: 3.1×FY 2024: 2.6×FY 2025: 1.6×FY 2026: 3.0×
FY 2017 5y median 2.6× FY 2026
Quick Ratio 1.9×
FY 2017: 1.6×FY 2018: 0.9×FY 2019: 1.6×FY 2020: 1.2×FY 2021: 1.5×FY 2022: 1.0×FY 2023: 2.0×FY 2024: 1.5×FY 2025: 1.0×FY 2026: 1.9×
FY 2017 5y median 1.5× FY 2026
Debt / Equity 1.5×
FY 2017: 0.4×FY 2018: 0.3×FY 2019: 0.5×FY 2020: 0.8×FY 2021: 1.1×FY 2022: 1.0×FY 2023: 0.9×FY 2024: 0.8×FY 2025: 1.5×FY 2026: 1.5×
FY 2017 5y median 1.0× FY 2026
Net Debt / EBITDA 3.6×
FY 2017: 1.4×FY 2018: 0.5×FY 2019: 0.9×FY 2020: 1.1×FY 2021: 3.2×FY 2022: 2.6×FY 2023: 1.8×FY 2024: 2.1×FY 2025: 2.5×FY 2026: 3.6×
FY 2017 5y median 2.5× FY 2026
Interest Coverage 8.4×
FY 2017: -2.4×FY 2018: 12.4×FY 2019: 8.4×FY 2020: 6.4×FY 2021: 5.3×FY 2022: 4.7×FY 2023: 10.7×FY 2024: 12.7×FY 2025: 22.8×FY 2026: 8.4×
FY 2017 5y median 10.7× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-03-28